 | Ketoconazole | IC50 | 57.0 [1] |
| Ketoconazole | Ki | 25.12 [1] |
 | Diltiazem | IC50 | 80000.0 [1] |
| Diltiazem | Ki | 100.0 [1] |
 | Amg-487 | IC50 | 9200.0 [1] |
 | Ritonavir | IC50 | 100.0 [1] |
| Ritonavir | Ki | 100.0 [1], 170.0 [2] |
 | Xolegel | IC50 | 136.0 [1] |
 | Nizoral | IC50 | 1260.0 [1] |
 | Bms-536924 | IC50 | 500.0 [1] |
 | Cyclosporin A | IC50 | 6500.0 [1], 6600.0 [2], 10000.0 [3] |
| Cyclosporin A | Ki | 300.0 [1], 890.0 [2], 7600.0 [3] |
 | Fluconazole | IC50 | 10000.0 [1] |
 | alpha-Naphthoflavone | IC50 | 10000.0 [1] |
 | Abiraterone | IC50 | 2700.0 [1] |
 | (S)-N-[1-(3-Morpholin-4-yl-phenyl)-ethyl]-3-phenyl-acrylamide | IC50 | 33000.0 [1] |
 | N-[(1R)-1-[3-(4-Hydroxyphenyl)-4-oxopyrido[2,3-d]pyrimidin-2-yl]ethyl]-N-(pyridin-3-ylmethyl)-2-[4-(trifluoromethoxy)phenyl]acetamide | IC50 | 27.0 [1], 68.0 [2], 650.0 [3], 2100.0 [4] |
| N-[(1R)-1-[3-(4-Hydroxyphenyl)-4-oxopyrido[2,3-d]pyrimidin-2-yl]ethyl]-N-(pyridin-3-ylmethyl)-2-[4-(trifluoromethoxy)phenyl]acetamide | Ki | 730.0 [1], 740.0 [2] |
 | Verapamil | IC50 | 4700.0 [1], 8193.0 [2], 12000.0 [3], 17600.0 [4], 76032.63 [5] |
 | Clotrimazole | IC50 | 20.0 [1], 50.0 [2], 100.0 [3], 300.0 [4], 500000.0 [5] |
 | Troleandomycin | IC50 | 7998.34 [1], 16000.0 [2], 20000.0 [3], 33000.0 [4], 61000.0 [5] |
 | Gingerol | IC50 | 21800.0 [1], 32000.0 [2], 37400.0 [3], 42900.0 [4], 73400.0 [5] |
 | Saxagliptin | IC50 | 50000.0 [1], 100000.0 [2] |
 | 4-(8-Fluoro-2-oxo-1,4-dihydroquinazolin-3-yl)-N-[(2R)-3-(7-methyl-1H-indazol-5-yl)-1-oxo-1-(4-piperidin-1-ylpiperidin-1-yl)propan-2-yl]piperidine-1-carboxamide | IC50 | 6700.0 [1], 7800.0 [2], 26000.0 [3], 40000.0 [4] |
 | 3-[5-[(4Ar,7aR)-2-amino-6-(5-fluoropyrimidin-2-yl)-3-methyl-4-oxo-5,7-dihydro-4aH-pyrrolo[3,4-d]pyrimidin-7a-yl]thiophen-3-yl]benzonitrile | IC50 | 1200.0 [1], 1900.0 [2], 30000.0 [3] |
 | Nifedipine | IC50 | 5620.0 [1], 10000.0 [2], 11000.0 [3], 46989.41 [4] |
 | Erythromycin | IC50 | 190.0 [1], 1900.0 [2], 33000.0 [3], 132129.56 [4] |
 | Cimetidine | IC50 | 10000.0 [1], 15000.0 [2], 1000000.0 [3] |
 | Indinavir | IC50 | 150.0 [1] |
 | Miconazole | IC50 | 180.0 [1], 851.14 [2], 5000.0 [3] |
 | Posaconazole | IC50 | 50.0 [1], 75.0 [2], 82.0 [3], 350.0 [4] |
 | 4-[(7-Chloroquinolin-4-yl)amino]-2-(diethylaminomethyl)phenol;hydrochloride | IC50 | 28000.0 [1], 100000.0 [2] |
 | Mibefradil | IC50 | 130.0 [1], 300.0 [2], 470.0 [3], 140000.0 [4] |
 | Nefazodone | IC50 | 15.0 [1], 1500.0 [2], 10000.0 [3] |
 | Dolutegravir | IC50 | 33000.0 [1], 54000.0 [2], 65000.0 [3], 100000.0 [4] |
 | (10)-Gingerol | IC50 | 7100.0 [1], 20800.0 [2], 21800.0 [3], 24900.0 [4] |
 | Shogaol | IC50 | 4000.0 [1], 8300.0 [2], 65200.0 [3], 77700.0 [4] |
 | Desethylamodiaquine | IC50 | 24000.0 [1], 100000.0 [2] |
 | 2-Phenylimidazole | IC50 | 10000.0 [1], 500000.0 [2] |
 | 4-Phenylimidazole | IC50 | 1500.0 [1], 58800.0 [2] |
 | 1-Phenylimidazole | IC50 | 1000.0 [1], 52500.0 [2] |
 | Climbazole | IC50 | 100.0 [1], 47500.0 [2] |
 | Paradol | IC50 | 30000.0 [1] |
 | (8)-Gingerol | IC50 | 8100.0 [1], 8700.0 [2], 10500.0 [3], 11600.0 [4] |
 | MK-7246 | IC50 | 7000.0 [1], 34000.0 [2] |
 | (1S,3S,5S)-2-[(2S)-2-Amino-2-(3,5-dihydroxy-1-adamantyl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile | IC50 | 200000.0 [1] |
 | Vericiguat | IC50 | 50000.0 [1] |
 | 2,3-Dimethyl-8-(2-ethyl-6-methylbenzylamino)-imidazo[1,2-a]pyridine-6-carboxamide | IC50 | 3800.0 [1], 3900.0 [2] |
 | 7-Methoxy-N-[[6-(3-methyl-1,2-thiazol-5-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]-1,5-naphthyridin-4-amine | IC50 | 26000.0 [1], 50000.0 [2] |
 | Auglurant | IC50 | 30000.0 [1], 133000.0 [2], 200000.0 [3] |
 | (3R)-N-Isoquinolin-3-ylspiro[1-azabicyclo[2.2.2]octane-3,5'-4H-1,3-oxazole]-2'-amine | IC50 | 40000.0 [1] |
 | 6-[2-[4-(2-Methylquinolin-5-yl)piperazin-1-yl]ethyl]-4H-imidazo[5,1-c][1,4]benzoxazine-3-carboxamide | IC50 | 9000.0 [1], 88000.0 [2], 100000.0 [3] |
 | 7-Methoxy-4-[[6-(3,4,5-trifluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methoxy]quinoline | IC50 | 2000.0 [1], 29000.0 [2] |
 | 2-(4-Fluorophenyl)-N-[6-methoxy-5-(4-methylimidazol-1-yl)pyridin-2-yl]-1-methylbenzimidazol-4-amine | IC50 | 2900.0 [1], 8700.0 [2] |
 | Linaprazan | IC50 | 8400.0 [1], 9000.0 [2], 12000.0 [3], 14000.0 [4] |
 | [3-[4-[[(3S,5R)-3,5-Dimethylpiperazin-1-yl]methyl]phenyl]pyridin-2-yl]-[4-(4-fluoroanilino)piperidin-1-yl]methanone | IC50 | 1400.0 [1], 20000.0 [2], 100000.0 [3] |
 | N-[(2R)-3-(1H-Indazol-5-yl)-1-oxo-1-(4-piperidin-1-ylpiperidin-1-yl)propan-2-yl]-4-(2-oxo-1,4-dihydroquinazolin-3-yl)piperidine-1-carboxamide | IC50 | 4000.0 [1], 40000.0 [2] |
 | (S,E)-N-(1-(4-Fluoro-3-morpholinophenyl)ethyl)-3-(4-fluorophenyl)acrylamide | IC50 | 18000.0 [1], 19000.0 [2], 21000.0 [3] |
 | 1-(3-(2-(4-(2-Methyl-5-quinolinyl)-1-piperazinyl)ethyl)phenyl)-2-imidazolidinone | IC50 | 21000.0 [1], 67000.0 [2] |
 | (2R)-2-(2,4-Difluorophenyl)-2-[(2R,5R)-5-(2,3-dihydro-1H-inden-2-yl)-2-(2-methylpropyl)-3,6-dioxopiperazin-1-yl]-N,N-dimethylacetamide | IC50 | 5000.0 [1], 31000.0 [2], 62000.0 [3], 89000.0 [4] |
 | N-[(2R)-3-(7-Methyl-1H-indazol-5-yl)-1-oxo-1-(4-piperidin-1-ylpiperidin-1-yl)propan-2-yl]-4-(2-oxo-1,4-dihydroquinazolin-3-yl)piperidine-1-carboxamide | IC50 | 6000.0 [1], 36000.0 [2] |
 | (1s,2s)-N-[4-(Phenylsulfonyl)phenyl]-2-(Pyridin-3-Yl)cyclopropanecarboxamide | IC50 | 90.0 [1], 680.0 [2] |
 | N-[[4-(6-Methylpyridin-3-yl)sulfonylphenyl]methyl]-1,3-dihydropyrrolo[3,4-c]pyridine-2-carboxamide | IC50 | 10000.0 [1] |
 | N-[[5-(1-Propan-2-ylpyrazol-4-yl)sulfonylpyridin-2-yl]methyl]furo[2,3-c]pyridine-2-carboxamide | IC50 | 10000.0 [1] |
 | N-Methyl-6-[2-[4-(2-methylquinolin-5-yl)piperazin-1-yl]ethyl]-4H-imidazo[5,1-c][1,4]benzoxazine-3-carboxamide | IC50 | 9000.0 [1], 82000.0 [2], 100000.0 [3] |
 | Ethyl 4-[10-[4-[2-[(6S,10R,17S)-17-hydroxy-10-methyl-3-oxo-2,6,7,8,9,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]acetyl]oxybutyl]-2,4-dioxopyrimido[4,5-b]quinolin-3-yl]butanoate | IC50 | 1000.0 [1], 1100.0 [2], 2500.0 [3], 4100.0 [4] |
 | 2-(3-Pyridyl)-2-(4-chlorophenyl)-1-[4-[4-(trifluoromethyl)phenyl]piperazino]ethanone | IC50 | 1200.0 [1], 7400.0 [2], 16000.0 [3], 20000.0 [4] |
 | Quercetin | IC50 | 2110.0 [1], 20000.0 [2] |
 | Voriconazole | IC50 | 13000.0 [1] |
 | Sporanox | IC50 | 32.6 [1], 50.4 [2], 70.0 [3] |
 | Metyrapone | IC50 | 3000.0 [1], 4931.74 [2] |
 | Artemisinine | IC50 | 50000.0 [1] |
| Artemisinine | Ki | 25000.0 [1] |
 | Nicardipine | IC50 | 380.0 [1], 420.0 [2], 30000.0 [3] |
 | Alosetron | IC50 | 600.0 [1] |
 | 1-Methylimidazole | IC50 | 10000.0 [1], 2697739.43 [2] |
 | 2-Methylimidazole | IC50 | 10000.0 [1], 1253141.17 [2] |
 | Liarozole | IC50 | 100.0 [1], 690.0 [2] |
 | Brivanib | IC50 | 18000.0 [1], 40000.0 [2] |
 | Metapro | Ki | 58000.0 [1], 287000.0 [2], 403000.0 [3] |
 | CID 57345320 | IC50 | 12000.0 [1], 20000.0 [2] |
 | 7-(4-Fluorobenzyloxy)-2,3-dimethyl-1-[(1S,2S)-2-methylcyclopropylmethyl]pyrrolo[2,3-d]pyridazine | IC50 | 56.23 [1], 6000.0 [2], 14000.0 [3] |
 | [1-[(2R,6R)-1-(4-Chlorophenyl)sulfonyl-6-ethylpiperidin-2-yl]cyclopropyl] 4-(1-hydroxy-2-methylpropan-2-yl)piperazine-1-carboxylate | IC50 | 2000.0 [1], 2200.0 [2] |
 | 3-[(2R)-2-Amino-2-phenylethyl]-5-(2-fluoro-3-methoxyphenyl)-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]pyrimidine-2,4-dione | IC50 | 100.0 [1] |
 | Benzamide, 2,3-dichloro-N-(2-methylpropyl)-N-(3S)-3-pyrrolidinyl- | IC50 | 30000.0 [1] |
 | 1-Cyano-3-(2-methyl-1-benzofuran-5-yl)-2-[(3S)-2-oxo-1-(2-oxo-2-pyrrolidin-1-ylethyl)azepan-3-yl]guanidine | IC50 | 18500.0 [1], 40000.0 [2], 200000.0 [3] |
 | Bms-344577 | IC50 | 39000.0 [1], 40000.0 [2], 200000.0 [3] |
 | (5-Pyrid-3-ylthien-2-YL)methylamine | IC50 | 56990.0 [1], 58700.0 [2] |
| (5-Pyrid-3-ylthien-2-YL)methylamine | Ki | 29400.0 [1] |
 | 4-[[(1R)-2-[5-(2-Fluoro-3-methoxyphenyl)-3-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-2,6-dioxopyrimidin-1-yl]-1-phenylethyl]amino]butanoic acid | IC50 | 36000.0 [1], 39810.72 [2] |
 | (5-(Pyridin-3-YL)furan-2-YL)methanamine | IC50 | 47100.0 [1], 47170.0 [2] |
| (5-(Pyridin-3-YL)furan-2-YL)methanamine | Ki | 23600.0 [1] |
 | 4-[[2-(3-Chlorophenyl)-2-hydroxyethyl]amino]-3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-1H-pyridin-2-one | IC50 | 18.0 [1], 46.0 [2] |
 | Unii-37IS6K16XE | IC50 | 4600.0 [1], 7200.0 [2], 8800.0 [3] |
 | 3-(1H-Imidazol-4-yl)pyridine | IC50 | 139900.0 [1] |
| 3-(1H-Imidazol-4-yl)pyridine | Ki | 70000.0 [1] |
 | (3R,4S)-N-[[3-Bromo-5-(3-methoxypropyl)-4-methylphenyl]methyl]-N-cyclopropyl-4-(1-methyl-2-oxopyridin-4-yl)piperidine-3-carboxamide | IC50 | 6500.0 [1], 16000.0 [2], 20000.0 [3] |
 | Antihistamine-1 | IC50 | 5000.0 [1] |
 | N-[(6Ar,8R,10aS)-10a-(4-chlorophenyl)sulfonyl-1,4-difluoro-6,6a,7,8,9,10-hexahydrobenzo[c]chromen-8-yl]-1,1,1-trifluoromethanesulfonamide | IC50 | 3500.0 [1], 9600.0 [2], 30000.0 [3] |
 | Pyridine, 3-(1-methyl-1H-imidazol-4-yl)- | IC50 | 261900.0 [1], 262000.0 [2] |
Calculator
